Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development
Tuesday, June 21, 2022Waters Corporation announced a collaboration with BioInfra a pioneering contract research organization CRO company for the pharmaceutical and clinical fields to jointly establish the ASEAN Academy for Bioanalysis The academy is dedicated to providing...
Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
Friday, June 17, 2022Humanigen Inc a latestage clinical biopharmaceutical company focused on preventing and treating an immune hyperresponse called cytokine storm today announced it entered into an agreement with PCI Pharma Services PCI a leading integrated global contra...
Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.
Friday, June 17, 2022Panbela Therapeutics Inc a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer today announced the closing of its acquisition of Cancer Prevention Pharmaceuticals Inc CPP a private clinical stage compan...
Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop Novel Antibody-Based Immuno-Oncology Therapies
Thursday, June 16, 2022Exelixis Inc and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel antibodies for use in IO therapeutics The collaboration is intended to e...
Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma
Thursday, June 16, 2022Kintara Therapeutics Inc a biopharmaceutical company focused on the development of new solid tumor cancer therapies today announced that the United States Food and Drug Administration FDA has granted Fast Track Designation FTD to Kintaras VAL for the...
Boehringer Ingelheim and CarthroniX announce partnership to pursue small molecule therapeutics in canine oncology
Wednesday, June 15, 2022Boehringer Ingelheim a global leader in animal health and CarthroniX a biopharmaceutical company focused on developing small moleculebased therapies for degenerative and agingrelated diseases announce that they have entered into a research collaborat...
Evotec enters a drug discovery collaboration with Janssen
Wednesday, June 15, 2022Evotec SE announced today that the Company has entered a drug discovery collaboration with Janssen Pharmaceutica NV one of the Janssen Pharmaceutical Companies of Johnson Johnson Janssen Evotecs innovative TargetAlloMod platforms will be evaluated t...
FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
Tuesday, June 14, 2022Eli Lilly and Company and Incyte announced today that the US Food and Drug Administration FDA has approved OLUMIANT baricitinib a oncedaily pill as a firstindisease systemic treatment for adults with severe alopecia areata AA available as mg mg and m...
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47
Tuesday, June 14, 2022Pfizer Inc MorphoSys US Inc a fully owned subsidiary of MorphoSys AG FSE MOR NASDAQMOR and Incyte NASDAQINCY today announced a clinical trial collaboration and supply agreement to investigate the immunotherapeutic combination of Pfizers TTI a novel S...
ImmunoGen Announces Research Collaboration with Oxford BioTherapeutics to Develop Novel Antibody-Drug Conjugates
Monday, June 13, 2022ImmunoGen Inc a leader in the expanding field of antibodydrug conjugates ADCs for the treatment of cancer today announced a multiyear collaboration to research novel firstinclass ADCs with Oxford BioTherapeutics OBT a clinical stage oncology company...
